Neurotez, Inc.

Neurotez Inc. is developing a drug to treat Leptin deficiency in Alzheimer’s patients.

Login to favorite a company

Visit SEC Page

Most Recent Valuation:

$NaN

Legal Name:

Founded:

State of HQ:

Neurotez Inc.

10/14/2005

Employees:

Company Description

Round Summary

Number of funding rounds

2 Total amount raised

$NaN

Round history

Screen Shot 2020-07-15 at 12.01.28 PM.pn

See round history

Early Bird Perk history

View early bird perks, deal notes, company financials, and more

Join Crowdonomics+

Company notes

Financials (up to prior 4 years)

Revenue

COGS

Gross margin | (%)

Taxes

SG&A, other

Net income

Cash/Equivalents

Accounts Receiv

Other Assets

Assets

Short term debt

Long term debt

Equity/other liabilities

Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.